--- title: "Enzyme Replacement Therapy Medicines" ocid: "ocds-h6vhtk-047915" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-047915" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-047915.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-047915.json" source: "Find A Tender Service" current_stage: "Award" buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")" published: "2024-08-15" --- # Enzyme Replacement Therapy Medicines Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") Current stage: Award OCID: ocds-h6vhtk-047915 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-047915) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-047915.json) ## Summary The Common Services Agency, more commonly known as NHS National Services Scotland (NSS), has completed the procurement process for the supply of Enzyme Replacement Therapy Medicines. This entails a framework agreement covering a 24-month contract duration with an optional 12-month extension. The procurement falls under the Pharmaceutical products category and targets entities constituted under the National Health Service (Scotland) Act 1978 and Integrated Joint Boards established by the Public Bodies (Joint Working) Scotland Act 2014. Located in Edinburgh, UKM region, the contract was signed on 18th July 2024, with an estimated value of £12,437,853 GBP. This procurement was conducted using a limited method without a prior call for competition, in accordance with intellectual property regulations. This tender presents significant growth opportunities for companies specialising in enzyme replacement therapies, particularly those capable of supplying Laronidase, Imiglucerase, Agalsidase beta, and Alglucosidase alfa medicinal products. Although the framework agreement has been awarded to Aventis Pharma Ltd Trading As Sanofi, understanding the procurement process and the requirements could benefit other businesses aiming to compete in future similar tenders. Companies with expertise in pharmaceutical manufacturing and supply, particularly those focusing on rare disease treatments, are well-suited to compete in this niche yet crucial market segment. ## Notice Supply of Enzyme Replacement Therapy Medicines (a-d) to NHS Scotland: - NP92624(a) Laronidase 500units/5ml solution for infusion vials 1 vial (Aldurazyme(r)) - NP92624(b) Imiglucerase 400unit powder for solution for infusion vials 1 vial (Cerezyme(r)) - NP92624(c) Agalsidase beta 35mg powder for solution for infusion vials 1 vial (Fabrazyme(r)) - NP92624(c) Agalsidase beta 5mg powder for solution for infusion vials 1 vial (Fabrazyme(r)) - NP92624(d) Alglucosidase alfa 50mg powder for solution for infusion vials 1 vial (Myozyme(r)) ### Lot Information Lot 1 The Framework Agreement is for the supply of Enzyme Replacement Therapy Medicines (a-d: Aldurazyme(r)/ Cerezyme(r)/ Fabrazyme(r)/ Fabrazyme(r)/ Myozyme(r)) to NHS Scotland. The Authority has awarded this framework as a Single supplier framework agreement to one (1) Framework Participant. ### Procurement Information The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/025940-2024 | | Notice type | Award Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Limited | | Procurement method details | Award procedure without prior publication of a call for competition | | Tender suitability | Not specified | | Awardee scale | Large | | All stages | Award | ## Dates | Field | Value | | --- | --- | | Publication date | 15 Aug 2024 | | Submission deadline | Not specified | | Future notice date | Not specified | | Award date | 1 Jul 2024 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | £12,437,853 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Cancelled | | Awards status | Active | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") | | Additional buyers | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) | | Locality | EDINBURGH | | Post town | Edinburgh | | Postcode | EH12 9EB | | Country | Scotland | | ITL 1 | TLM Scotland | | ITL 2 | TLM1 East Central Scotland | | ITL 3 | TLM13 City of Edinburgh | | Local authority | City of Edinburgh | | Electoral ward | Drum Brae/Gyle | | Westminster constituency | Edinburgh South West | | Delivery location | TLM Scotland | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 1 | | Supplier names | AVENTIS PHARMA LTD TRADING AS SANOFI | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 15 Aug 2024 at 10:45 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/025940-2024 - 2 Jul 2024 at 11:52 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/020101-2024 ## Notice URLs - http://www.nss.nhs.scot/browse/procurement-and-logistics - https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000774962 - https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883 ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-047915. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-047915.json.